leucyl-aspartyl-valine has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharya, S; Chan, W; Jasti, B; Li, X; Zhong, S | 1 |
1 other study(ies) available for leucyl-aspartyl-valine and Malignant Melanoma
| Article | Year |
|---|---|
Leucine-Aspartic Acid-Valine sequence as targeting ligand and drug carrier for doxorubicin delivery to melanoma cells: in vitro cellular uptake and cytotoxicity studies.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Delivery Systems; Humans; Inhibitory Concentration 50; Integrin alpha4beta1; Ligands; Melanoma; Molecular Structure; Oligopeptides; Polymerase Chain Reaction | 2009 |